BioMarin Pharmaceutical | BMRN - 净收入

金融业

USD

USD 8.59B

现金及等价物

USD 2.22B

USD 199.48M

USD 4.61B

USD 793.15M

USD 1.44B

USD 129.65M

USD 146.05M

3.04K

EPS每股收益

USD 0.76

股本和储备

USD 6.21B

USD 571.21M

债务利息支出

USD 14.96M

USD 22.56M

USD 1.43B

USD 10.76B

USD 105.53M

USD 636.56M

USD 129.65M

普通股股本

USD 193.27M

15.28

USD 141.2M

USD 766M

销售和管理费用

USD 258.28M

USD 1.27B

贸易债权人

USD 793.15M

应收帐款人

USD 903.91M

	净收入	更改		日
Acadia Pharmaceuticals	USD 3.64M		269.93M	2026-03
Agios Pharmaceuticals	USD -99.11M		8.93M	2026-03
Alnylam Pharmaceuticals	USD 205.99M		19.57M	2026-03
Amgen	USD 1.82B		486M	2026-03
Bayer	EUR 2.76B		6.52B	2026-03
Biogen	USD 319.5M		368.4M	2026-03
BioMarin Pharmaceutical	USD 105.53M		152.1M	2026-03
Gilead Sciences	USD 2.02B		162M	2026-03
Incyte	USD 303.33M		4.05M	2026-03
Insmed	USD -163.56M		164.92M	2026-03
Ionis Pharmaceuticals	USD -93M		136M	2026-03
Moderna	USD -1.34B		517M	2026-03
Neurocrine Biosciences	USD 197.9M		44.2M	2026-03
PTC Therapeutics	USD -2.81M		132.16M	2026-03
Puma Biotechnology	USD 20.32M		24.85M	2024-09
Regeneron Pharmaceuticals	USD 727.2M		117.4M	2026-03
Roche Holding	CHF 5.47B		1.76B	2025-12
Sangamo BioSciences	USD -36.13M		12.96M	2024-06
Sanofi	EUR -801M		3.6B	2025-12
Sarepta Therapeutics	USD 330.96M		743.18M	2026-03
Ultragenyx Pharmaceutical	USD -185M		56M	2026-03
United Therapeutics	USD 274.9M		89.4M	2026-03
Vertex Pharmaceuticals	USD 1.03B		159.7M	2026-03